The healthcare world is observing a significant shift in blood sugar therapy with the emergence of GLP-1 transdermal devices. These patches offer a potentially more user-friendly alternative to shots of GLP-1 receptor agonists, minimizing the frequency of daily needle pricks. The approach administers the compound directly through the skin, possi… Read More